My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 219

    1.

    Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes.

    Di Loreto C, Fanelli C, Lucidi P, Murdolo G, De Cicco A, Parlanti N, Ranchelli A, Fatone C, Taglioni C, Santeusanio F, De Feo P.

    Diabetes Care. 2005 Jun;28(6):1295-302.PMID: 15920042 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects.

    Di Loreto C, Fanelli C, Lucidi P, Murdolo G, De Cicco A, Parlanti N, Santeusanio F, Brunetti P, De Feo P.

    Diabetes Care. 2003 Feb;26(2):404-8.PMID: 12547870 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes.

    Walker KZ, Piers LS, Putt RS, Jones JA, O'Dea K.

    Diabetes Care. 1999 Apr;22(4):555-61.PMID: 10189531 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of 2,000 kcal per week of walking and stair climbing on physical fitness and risk factors for coronary heart disease.

    Leon AS, Casal D, Jacobs D Jr.

    J Cardiopulm Rehabil. 1996 May-Jun;16(3):183-92.PMID: 8761839 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effect of pioglitazone on glycemic and lipid parameters and adverse events in elderly patients with type 2 diabetes mellitus: a post hoc analysis of four randomized trials.

    Rajagopalan R, Xu Y, Abbadessa M; Quartet Study Group.

    Am J Geriatr Pharmacother. 2006 Jun;4(2):123-33.PMID: 16860259 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    7.

    Impact of physical activity on cardiovascular risk factors in IDDM.

    Lehmann R, Kaplan V, Bingisser R, Bloch KE, Spinas GA.

    Diabetes Care. 1997 Oct;20(10):1603-11.PMID: 9314643 [PubMed - indexed for MEDLINE]Related articles

    8.

    Physical activity is associated with risk factors for chronic disease across adult women's life cycle.

    Woolf K, Reese CE, Mason MP, Beaird LC, Tudor-Locke C, Vaughan LA.

    J Am Diet Assoc. 2008 Jun;108(6):948-59.PMID: 18502225 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy of a pedometer-based physical activity program on parameters of diabetes control in type 2 diabetes mellitus.

    Araiza P, Hewes H, Gashetewa C, Vella CA, Burge MR.

    Metabolism. 2006 Oct;55(10):1382-7.PMID: 16979410 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

    Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

    Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

    11.

    Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial.

    Simmons RK, Griffin SJ, Steele R, Wareham NJ, Ekelund U; ProActive Research Team.

    Diabetologia. 2008 May;51(5):787-94. Epub 2008 Mar 4.PMID: 18317727 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of two different 18-week walking programmes on aerobic fitness, selected blood lipids and factor XIIa.

    Woolf-May K, Kearney EM, Jones DW, Davison RC, Coleman D, Bird SR.

    J Sports Sci. 1998 Nov;16(8):701-10.PMID: 10189075 [PubMed - indexed for MEDLINE]Related articles

    14.

    Increasing physical activity in people with type 2 diabetes.

    Kirk A, Mutrie N, MacIntyre P, Fisher M.

    Diabetes Care. 2003 Apr;26(4):1186-92.PMID: 12663595 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A physical activity programme and its effects on insulin resistance and oxidative defense in obese male patients with type 2 diabetes mellitus.

    Lazarevic G, Antic S, Cvetkovic T, Vlahovic P, Tasic I, Stefanovic V.

    Diabetes Metab. 2006 Dec;32(6):583-90.PMID: 17296511 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Walking for exercise--does three times per week influence risk factors in type 2 diabetes?

    Fritz T, Wändell P, Aberg H, Engfeldt P.

    Diabetes Res Clin Pract. 2006 Jan;71(1):21-7. Epub 2005 Jul 6.PMID: 16005099 [PubMed - indexed for MEDLINE]Related articles

    17.

    Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions.

    Hambrecht R, Niebauer J, Marburger C, Grunze M, Kälberer B, Hauer K, Schlierf G, Kübler W, Schuler G.

    J Am Coll Cardiol. 1993 Aug;22(2):468-77.PMID: 8335816 [PubMed - indexed for MEDLINE]Related articles

    18.

    Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.

    Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL.

    Clin Ther. 2007 Jan;29(1):74-83.PMID: 17379048 [PubMed - indexed for MEDLINE]Related articles

    19.

    Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

    Meis SB, Schuster D, Gaillard T, Osei K.

    Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity